Ms Sara Al-Badran

email: Sara.Al-Badran@glasgow.ac.uk
pronouns: She/her/hers

Import to contacts

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021
Number of items: 6.

2024

Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)

Shamis, S. A. K., Savioli, F., Ammar, A. , Al-Badran, S. S.F., Hatthakarnkul, P. , Leslie, H. , Mallon, E., Jamieson, N. B. , McMillan, D. C. and Edwards, J. (2024) Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay. Histology and Histopathology: Cellular and Molecular Biology, 39, pp. 177-200. (doi: 10.14670/HH-18-655) (PMID:37681672)

2023

Edwards, J. et al. (2023) Association of Wnt Signalling With Metachronous Colonic Polyp Risk. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 232. (doi: 10.1200/JCO.2023.41.4_suppl.232)

Johnstone, M. S., Al-Badran, S. S.F., Stoops, R., Hay, J., Jawny, J., Lynch, G., McSorley, S. T. and Edwards, J. (2023) Immunohistochemical Assessment of COX2, P53, and Beta-catenin Expression to Predict Metachronous Lesion Development Following Polypectomy. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 234. (doi: 10.1200/JCO.2023.41.4_suppl.234)

2022

Patel, M., McAllister, M., Nagaraju, R., Al Badran, S. S. F., Edwards, J. , McBain, A. J., Barriuso, J. and Aziz, O. (2022) The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player? Critical Reviews in Oncology/Hematology, 180, 103856. (doi: 10.1016/j.critrevonc.2022.103856) (PMID:36257533)

2021

Al-Badran, S. S.F. et al. (2021) Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. Journal of Pathology: Clinical Research, 7(2), pp. 121-134. (doi: 10.1002/cjp2.193) (PMID:33338327)

This list was generated on Mon Jun 24 01:43:22 2024 BST.
Number of items: 6.

Articles

Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)

Shamis, S. A. K., Savioli, F., Ammar, A. , Al-Badran, S. S.F., Hatthakarnkul, P. , Leslie, H. , Mallon, E., Jamieson, N. B. , McMillan, D. C. and Edwards, J. (2024) Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay. Histology and Histopathology: Cellular and Molecular Biology, 39, pp. 177-200. (doi: 10.14670/HH-18-655) (PMID:37681672)

Patel, M., McAllister, M., Nagaraju, R., Al Badran, S. S. F., Edwards, J. , McBain, A. J., Barriuso, J. and Aziz, O. (2022) The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player? Critical Reviews in Oncology/Hematology, 180, 103856. (doi: 10.1016/j.critrevonc.2022.103856) (PMID:36257533)

Al-Badran, S. S.F. et al. (2021) Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. Journal of Pathology: Clinical Research, 7(2), pp. 121-134. (doi: 10.1002/cjp2.193) (PMID:33338327)

Conference or Workshop Item

Edwards, J. et al. (2023) Association of Wnt Signalling With Metachronous Colonic Polyp Risk. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 232. (doi: 10.1200/JCO.2023.41.4_suppl.232)

Johnstone, M. S., Al-Badran, S. S.F., Stoops, R., Hay, J., Jawny, J., Lynch, G., McSorley, S. T. and Edwards, J. (2023) Immunohistochemical Assessment of COX2, P53, and Beta-catenin Expression to Predict Metachronous Lesion Development Following Polypectomy. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 234. (doi: 10.1200/JCO.2023.41.4_suppl.234)

This list was generated on Mon Jun 24 01:43:22 2024 BST.